Divi's Laboratories - Stable Performer
Topic Statement:
Divi's Laboratories has shown resilience amidst the broad market correction, with stable price movements and potential for accumulation near the 180-day moving average.
Key points:
1. Company reported a profit growth of 64% QoQ for the third quarter.
2. Price broke down from the up-trending channel, transitioning into a sideways pattern.
3. Strong resistance is present at the 6000 level.
4. The stock repeatedly approaches the 180-day moving average, presenting a good buying opportunity.
Divi's Laboratories has shown resilience amidst the broad market correction, with stable price movements and potential for accumulation near the 180-day moving average.
Key points:
1. Company reported a profit growth of 64% QoQ for the third quarter.
2. Price broke down from the up-trending channel, transitioning into a sideways pattern.
3. Strong resistance is present at the 6000 level.
4. The stock repeatedly approaches the 180-day moving average, presenting a good buying opportunity.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.